Provided by Tiger Trade Technology Pte. Ltd.

NRX Pharmaceuticals Inc.

2.21
-0.1750-7.35%
Volume:716.87K
Turnover:1.59M
Market Cap:72.91M
PE:-1.65
High:2.32
Open:2.29
Low:2.14
Close:2.38
52wk High:3.84
52wk Low:1.58
Shares:33.07M
Float Shares:24.28M
Volume Ratio:0.57
T/O Rate:2.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3400
EPS(LYR):-2.3605
ROE:-682.61%
ROA:-121.85%
PB:-4.58
PE(LYR):-0.93

Loading ...

NRx Pharmaceuticals (NASDAQ: NRXP) Reports Q3 Results and Advances NRX-100 and NRX-101 Regulatory Programs

TIPRANKS
·
Nov 18, 2025

NRX Pharmaceuticals Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Nov 17, 2025

NRX Pharmaceuticals Q3 EPS $(0.27) May Not Be Comparable To $0.18 Estimate, Sales $242.000K May Not Be Comparable To $15.000M Estimate

Benzinga
·
Nov 17, 2025

NRX Pharmaceuticals posts Q3 loss and reports first revenue after Dura Medical acquisition

Reuters
·
Nov 17, 2025

NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) Reports Third Quarter 2025 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
Nov 17, 2025

NRX Pharmaceuticals Inc - Refiles Anda for Ketafree, Expects Q2 2026 Gdufa Date

THOMSON REUTERS
·
Nov 17, 2025

Press Release: NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Dow Jones
·
Nov 17, 2025

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter 2025 Financial Results on November 17, 2025

GlobeNewswire
·
Nov 12, 2025

NRX Pharmaceuticals Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Nov 11, 2025

NRx Pharmaceuticals (NASDAQ: NRXP) Launches HOPE Therapeutics’ One-Day TMS Protocol for Treatment-Resistant Depression in Florida

TIPRANKS
·
Nov 11, 2025

HOPE Therapeutics Launches One-Day Depression Treatment in Florida

Reuters
·
Nov 10, 2025

Hope Therapeutics, Inc., an NRX Pharmaceuticals Subsidiary, Announces First-in-Florida Initiation of One Day (One-D) Depression Treatment in Partnership With Ampa Health

THOMSON REUTERS
·
Nov 10, 2025

NRX Pharmaceuticals Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
Oct 30, 2025

NRX Pharmaceuticals Inc : Ascendiant Capital Markets Raises Target Price to $47 From $46

THOMSON REUTERS
·
Oct 30, 2025

HOPE Therapeutics Acquires Cohen & Associates and Appoints Dr. Rebecca Cohen as Medical Director

Reuters
·
Oct 24, 2025

NRX Pharmaceuticals Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Oct 21, 2025

Hope Therapeutics - Acquisition Expected to Be Accretive to Co's Revenue and Ebitda

THOMSON REUTERS
·
Oct 20, 2025

Hope Therapeutics, Inc. and NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) Announce Inclusion of Cohen & Associates, Llc of Sarasota, Fl Into the Hope Network and Appointment of DR. Rebecca Cohen as Hope Medical Director

THOMSON REUTERS
·
Oct 20, 2025

Press Release: HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Inclusion of Cohen & Associates, LLC of Sarasota, FL into the HOPE Network and Appointment of Dr. Rebecca Cohen as HOPE Medical Director

Dow Jones
·
Oct 20, 2025

NRx Pharmaceuticals (NASDAQ: NRXP) Pursues Dual Pathway for Preservative-Free Ketamine-Based Therapies

TIPRANKS
·
Oct 18, 2025